Search
for
Sort by
Research 331–360 of 555
- Engineering a New Mouse Model for Vitiligo
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- The role of WNT10B in physiology and disease: A 10-year update
- Laser-Induced Koebner-Related Skin Reactions: A Clinical Overview
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- RETRACTED: Clinical observation of ultraviolet therapy combined with autologous platelet‐rich plasma in the treatment of chronic refractory wounds
- Exosomes versus Platelet-rich Plasma in Hair Loss Therapy: A Comprehensive Literature Review
- Adolopment of clinical practice guidelines and creation of referral pathways for dermatological conditions in Pakistan
- The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Atypical Presentation of Lichen Planopilaris: Presentation of Two Cases and Review
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Antroquinonol Exerts Immunosuppressive Effect on CD8<sup>+</sup> T Cell Proliferation and Activation to Resist Depigmentation Induced by H<sub>2</sub>O<sub>2</sub>
- A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective
- Vitamin D Status Assessment: Lack of Correlation between Serum and Hair 25-Hydroxycholecalciferol Levels in Healthy Young Adults
- Microneedling for Cutaneous Manifestations of Autoimmune Disease: A Scoping Review
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Spectrum of Phenotypes Associated with Human MC1R Variations
- The History and Current Status of Platelet-Rich Plasma Therapy in Dermatology
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- GATA3 inhibits proliferation and induces expression of both early and late differentiation markers in keratinocytes of the human epidermis
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- Role of nutritional supplements in selected dermatological disorders: A review
- Dietary Habits in Japanese Patients with Alopecia Areata
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Advances in the human skin microbiota and its roles in cutaneous diseases
- The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases